Cargando…
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
BACKGROUND: Triple negative breast cancer (TNBC) lacks both early detection biomarkers and viable targeted therapeutics. Moreover, chemotherapy only produces 20–30% pathologic complete response. Because miRNAs are frequently dysregulated in breast cancer and have broad tissue effects, individual or...
Autores principales: | Li, Hao-Yi, Liang, Jui-Lin, Kuo, Yao-Lung, Lee, Hao-Hsien, Calkins, Marcus J., Chang, Hong-Tai, Lin, Forn-Chia, Chen, Yu-Chia, Hsu, Tai-I, Hsiao, Michael, Ger, Luo-Ping, Lu, Pei-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738224/ https://www.ncbi.nlm.nih.gov/pubmed/29258605 http://dx.doi.org/10.1186/s13058-017-0918-2 |
Ejemplares similares
-
Bioinformatics analysis of the common targets of miR-223-3p, miR-122-5p, and miR-93-5p in polycystic ovarian syndrome
por: Zou, Liping, et al.
Publicado: (2023) -
Identification of Circulating miR-22-3p and miR-93-5p as Stable Endogenous Control in Tuberculosis Study
por: Korma, Workneh, et al.
Publicado: (2020) -
MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma
por: Dong, Wei, et al.
Publicado: (2021) -
miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
por: Li, Ye, et al.
Publicado: (2020) -
Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)